Cardiovascular Fitness and Venous Function in Trained and Untrained Subjects

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT01215630
First received: October 4, 2010
Last updated: January 9, 2013
Last verified: January 2013
  Purpose

The primary aim is to study the relationship between vascular function, cardiovascular fitness and age in healthy subjects. Individuals with the highest cardiovascular fitness will have the greatest arterial inflow independent of age.


Condition Intervention
Healthy Subjects
Behavioral: Aerobic Interval Training

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Cardiovascular Fitness and Venous Function in Trained and Untrained Subjects

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Venous Compliance [ Time Frame: 2 weeks ] [ Designated as safety issue: No ]
    Echocardiography; Test - retest


Secondary Outcome Measures:
  • Maximal oxygen uptake [ Time Frame: one test at baseline ] [ Designated as safety issue: No ]
    Cardiopulmonary testing


Biospecimen Retention:   Samples Without DNA

Blood samples


Enrollment: 30
Study Start Date: October 2010
Study Completion Date: May 2012
Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Healthy subjects
Men Women Age; 18-75
Behavioral: Aerobic Interval Training
One interval training session

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Healthy men and women, aged 18-75 yrs

Criteria

Inclusion Criteria:

  • Healthy subjects, 18-75 years of age

Exclusion Criteria:

  • Inability to exercise due to musculoskeletal conditions
  • Known ischemic cardiovascular disease
  • Smoking or tobacco use
  • Acute medical conditions
  • Active infections
  • Pharmacotherapy with known vascular effects
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01215630

Locations
Norway
Norwegian University of Science and Technology
Trondheim, Norway, 7491
Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Principal Investigator: Trine Karlsen, PhD Norwegian University of Science and Technology
  More Information

No publications provided

Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT01215630     History of Changes
Other Study ID Numbers: REK 2010/1512-2
Study First Received: October 4, 2010
Last Updated: January 9, 2013
Health Authority: Norway: Ethics Committee

Keywords provided by Norwegian University of Science and Technology:
Veins
Exercise tests
maximal oxygen uptake
VO2max

ClinicalTrials.gov processed this record on May 19, 2013